Therefore, AR antagonists could be regarded as promising drugs for clinical glioblastoma treatment.282,283 Orozco et al. discovered that dutasteride, cyproterone, and flutamide can significantly reduce glioblastoma cell proliferation and invasion. Here, AR is linked to glioblastoma.